Pricing Log in Create free account

Canton Strategic Holdings, Inc. (CNTN) vs Molecular Partners AG Sponsored ADR (MOLN)

Canton Strategic Holdings, Inc. and Molecular Partners AG Sponsored ADR are both Biotechnology companies. Canton Strategic Holdings, Inc. and Molecular Partners AG Sponsored ADR are of similar size ($149.0M and $143.5M). Molecular Partners AG Sponsored ADR has negative trailing earnings, so its P/E is not meaningful; Canton Strategic Holdings, Inc. trades at 9.0×. Across the 9 metrics below, Canton Strategic Holdings, Inc. leads on 8 and Molecular Partners AG Sponsored ADR on 1.

Valuation

Metric CNTN MOLN Biotechnology median
P/E 9.01 n/m 8.50
P/S n/m 24.43 9.71
P/B 0.81 1.86 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m 9.21 9.21
Earnings yield 11.10% (48.03%) (33.15%)
Free cash flow yield (6.01%) (41.59%) (25.50%)

Profitability

Metric CNTN MOLN Biotechnology median
Gross margin — 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (43.10%) (63.89%) (56.36%)
Return on assets (34.60%) (52.73%) (48.04%)
Return on invested capital (8.11%) 0.00% 0.00%

Growth

Metric CNTN MOLN Biotechnology median
Revenue growth (TTM) — (27.99%) 6.02%
EPS growth (last fiscal year) 88.10% (9.94%) 30.26%
Revenue growth, 5-year CAGR — (23.12%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CNTN MOLN Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 15.70 7.27 4.72
Net debt to EBITDA 0.85 1.66 0.96

Dividend

Metric CNTN MOLN Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CNTN MOLN Biotechnology median
Market cap 149.01m 143.47m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack